Hybrid total-body pet scanners—current status and future perspectives
Purpose Since the 1990s, PET has been successfully combined with MR or CT systems. In
the past years, especially PET systems have seen a trend towards an enlarged axial field of …
the past years, especially PET systems have seen a trend towards an enlarged axial field of …
Long axial field-of-view PET/CT devices: are we ready for the technological revolution?
L Filippi, A Dimitrakopoulou-Strauss… - Expert Review of …, 2022 - Taylor & Francis
In last decades hybrid imaging, combining molecular and anatomical data in a unique,
synergistic approach, has thoroughly changed the face of medical diagnostics [1, 2]. In …
synergistic approach, has thoroughly changed the face of medical diagnostics [1, 2]. In …
Performance characteristics of the Biograph Vision Quadra PET/CT system with a long axial field of view using the NEMA NU 2-2018 standard
GA Prenosil, H Sari, M Fürstner… - Journal of nuclear …, 2022 - Soc Nuclear Med
Our purpose was to evaluate the performance of the Biograph Vision Quadra PET/CT
system. This new system is based on the Biograph Vision 600, using the same silicon …
system. This new system is based on the Biograph Vision 600, using the same silicon …
Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET/CT
Purpose To investigate the performance of the new long axial field-of-view (LAFOV)
Biograph Vision Quadra PET/CT and a standard axial field-of-view (SAFOV) Biograph Vision …
Biograph Vision Quadra PET/CT and a standard axial field-of-view (SAFOV) Biograph Vision …
Positronium imaging with the novel multiphoton PET scanner
In vivo assessment of cancer and precise location of altered tissues at initial stages of
molecular disorders are important diagnostic challenges. Positronium is copiously formed in …
molecular disorders are important diagnostic challenges. Positronium is copiously formed in …
Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Evaluation of Advanced Lung Cancer
L Wang, G Tang, K Hu, X Liu, W Zhou, H Li, S Huang… - Radiology, 2022 - pubs.rsna.org
Background Gallium 68 (68Ga)–labeled fibroblast-activation protein inhibitor (FAPI) has
recently been introduced as a promising tumor imaging agent. Purpose To compare 68Ga …
recently been introduced as a promising tumor imaging agent. Purpose To compare 68Ga …
First results on kinetic modelling and parametric imaging of dynamic 18F-FDG datasets from a long axial FOV PET scanner in oncological patients
Purpose To investigate the kinetics of 18 F-fluorodeoxyglucose (18 F-FDG) by positron
emission tomography (PET) in multiple organs and test the feasibility of total-body …
emission tomography (PET) in multiple organs and test the feasibility of total-body …
Simulating NEMA characteristics of the modular total-body J-PET scanner—an economic total-body PET from plastic scintillators
P Moskal, P Kowalski, RY Shopa… - Physics in Medicine …, 2021 - iopscience.iop.org
The purpose of the presented research is estimation of the performance characteristics of
the economic total-body Jagiellonian-PET system (TB-J-PET) constructed from plastic …
the economic total-body Jagiellonian-PET system (TB-J-PET) constructed from plastic …
Positronium image of the human brain in vivo
Positronium is abundantly produced within the molecular voids of a patient's body during
positron emission tomography (PET). Its properties dynamically respond to the submolecular …
positron emission tomography (PET). Its properties dynamically respond to the submolecular …
[18F]FAPI-42 PET imaging in cancer patients: optimal acquisition time, biodistribution, and comparison with [68Ga]Ga-FAPI-04
K Hu, L Wang, H Wu, S Huang, Y Tian, Q Wang… - European Journal of …, 2022 - Springer
Abstract Purpose [18 F] FAPI-42 is a new fibroblast activation protein (FAP)-specific tracer
used for cancer imaging. Here, we describe the optimal acquisition time and in vivo …
used for cancer imaging. Here, we describe the optimal acquisition time and in vivo …